Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal. [electronic resource]
Producer: 20110714Description: 41-7 p. digitalISSN:- 1178-7023
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.